Biogen
Biogen is a global biotechnology company focused on developing and delivering innovative therapies for serious neurological and neurodegenerative diseases. Their research and development efforts span a broad range of therapeutic areas, including multiple sclerosis (MS), Alzheimer's disease, spinal muscular atrophy (SMA), and other neurological disorders. Biogen employs a diverse team of scientists, researchers, and professionals dedicated to advancing the understanding and treatment of these debilitating conditions. The company's portfolio includes both marketed products and a robust pipeline of investigational therapies, reflecting a commitment to continuous innovation in the field of neurology. Biogen collaborates extensively with academic institutions, research organizations, and other biotechnology companies to accelerate the pace of discovery and drug development. Their approach encompasses the entire drug development process, from early-stage research and clinical trials to commercialization and post-market surveillance. A significant part of their operations involves manufacturing and distributing their products globally, ensuring patient access to their therapies. The company is actively involved in patient advocacy and education initiatives to support individuals and families impacted by neurological diseases.
About Us
- Founded in 1978, Biogen initially focused on interferon research but has expanded into broader neurological therapies. - The company has a history of scientific excellence and innovation in developing novel treatments for neurological conditions. - Biogen has achieved significant milestones, introducing groundbreaking therapies impacting diseases like multiple sclerosis. - Biogen's commitment to R&D and global access to therapies makes it a leading biotechnology company. - Deep scientific expertise and strong collaborations drive continuous innovation, improving lives worldwide.
Vision
To be the world's leading biotechnology company focused on the discovery and development of innovative therapies for neurological and neurodegenerative diseases. To significantly improve the lives of patients and their families affected by these devastating illnesses, driving progress in understanding and treating these conditions through cutting-edge science and collaborative partnerships.
Mission
To discover, develop, and deliver worldwide innovative therapies that change the course of serious neurological diseases.
Culture
- Biogen cultivates a collaborative, innovative, and scientifically excellent culture that values diversity and inclusion. - They foster a supportive and inclusive environment empowering employees to contribute their unique skills. - Decision-making is data-driven, emphasizing scientific rigor. - The company encourages risk-taking and views failure as a learning opportunity. - Biogen prioritizes ethical conduct and responsible business practices.
Specialties & Industries
Open Positions
No open positions at the moment
Check back later for new opportunities